NRX Pharmaceuticals, Inc. (NRXP) earnings

NRXP earnings moved a median of +0.38% by the close. Quarterly and annual NRXP reports and results, each read against the price at its own news timestamp. Back to the NRXP overview →

29 measured NRXP earnings events.

Where these NRXP earnings landedvs 28 measured NRXP earnings reactions
NRXP earningsMiddle 50% · -4.27% to +5.04%Zero: 0.00%Median: +0.38%Median +0.38%-8.00%0+8.00%
Middle 50% of NRXP earnings reactions-4.27% to +5.04%
Median reaction (to close)+0.38%
Measured reactions28
Point-in-time · zero look-ahead

Half of the 28 NRXP earnings events with a measured close landed between -4.27% and +5.04%; 50% closed up.

DateHeadlineEvent5-minTo close
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ETPress release+5.16%+10.64%
Form 10-Q NRX Pharmaceuticals, For: Jun 30SEC filing · Form 10-Q+5.16%+10.64%
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate UpdatePress release-2.06%-8.11%
Form 10-Q NRX Pharmaceuticals, For: Mar 31SEC filing · Form 10-Q-2.06%-8.11%
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate UpdatePress release-1.34%+7.72%
Form 10-K NRX Pharmaceuticals, For: Dec 31SEC filing · Form 10-K-0.27%+13.30%
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate UpdatePress release+0.87%-7.86%
Form 10-Q NRX Pharmaceuticals, For: Sep 30SEC filing · Form 10-Q+0.87%-7.86%
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025Press release+0.80%+6.02%
Form 10-Q NRX Pharmaceuticals, For: Jun 30SEC filing · Form 10-Q-8.30%-3.50%
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatePress release-8.30%-3.50%
Form NT 10-Q NRX Pharmaceuticals, For: Jun 30SEC filing · Form NT-4.34%+4.71%
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025Press release+2.88%+0.76%
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025Press release+3.38%—
Form 10-Q NRX Pharmaceuticals, For: Mar 31SEC filing · Form 10-Q+0.43%+4.25%
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate UpdatePress release+0.43%+4.25%
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025Press release+0.38%+1.46%
Form 10-K/A NRX Pharmaceuticals, For: Dec 31SEC filing · Form 10-K-0.24%-1.42%
Form 10-K NRX Pharmaceuticals, For: Dec 31SEC filing · Form 10-K-4.25%-12.77%
Form 10-Q NRX Pharmaceuticals, For: Sep 30SEC filing · Form 10-Q+0.00%+2.59%
Form 10-Q NRX Pharmaceuticals, For: Jun 30SEC filing · Form 10-Q-2.14%-6.95%
Form 10-Q NRX Pharmaceuticals, For: Mar 31SEC filing · Form 10-Q-3.10%+0.00%
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business UpdatePress release-3.10%+0.00%
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024Press release-1.06%-0.35%
Form 10-K/A NRX Pharmaceuticals, For: Dec 31SEC filing · Form 10-K+6.14%+13.16%
Form 10-K NRX Pharmaceuticals, For: Dec 31SEC filing · Form 10-K+6.34%+11.70%
Form 10-Q NRX Pharmaceuticals, For: Sep 30SEC filing · Form 10-Q-1.98%-6.58%
NRx Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdatePress release-2.86%+0.00%
NRx Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 14, 2023Press release+0.00%+2.00%
That’s how NRXP usually reacts to earnings — get an email when it moves on news →
Keep exploring

More NRXP: analyst actions → · SEC filings → · NRXP overview →